Amylyx Pharmaceuticals In...

AI Score

0

Unlock

3.47
0.02 (0.58%)
At close: Jan 29, 2025, 3:59 PM
3.50
0.86%
After-hours Jan 29, 2025, 07:58 PM EST

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY23 FY22 FY21 FY20 FY19
Cash & Equivalents 170.20M 62.53M 50.19M 12.88M 3.09M
Short-Term Investments 201.16M 284.42M 45.93M n/a n/a
Long-Term Investments n/a 719.00K 189.00K 189.00K n/a
Other Long-Term Assets 46.38M 466.00K 3.44M 125.00K 18.00K
Receivables 40.05M 15.31M n/a n/a n/a
Inventory 38.32M 9.77M n/a n/a n/a
Other Current Assets 14.93M 10.11M 8.83M 762.00K 137.00K
Total Current Assets 464.67M 382.13M 101.51M 13.64M 3.20M
Property-Plant & Equipment 6.41M 8.13M 474.00K 151.00K n/a
Goodwill & Intangibles n/a n/a n/a n/a n/a
Total Long-Term Assets 52.79M 9.32M 4.10M 465.00K 18.00K
Total Assets 517.45M 391.45M 105.61M 14.10M 3.22M
Account Payables 22.06M 6.26M 4.37M 3.61M 2.19M
Deferred Revenue n/a n/a n/a n/a n/a
Short-Term Debt 2.26M 4.08M n/a n/a n/a
Other Current Liabilities 57.72M 36.27M 13.02M 3.71M 2.33M
Total Current Liabilities 82.04M 46.61M 17.40M 7.33M 4.53M
Long-Term Debt 1.98M 4.24M n/a 1.43M 14.93M
Other Long-Term Liabilities n/a n/a 35.00K 72.06M 9.11M
Total Long-Term Liabilities 1.98M 4.24M 239.39M 73.50M 24.05M
Total Liabilities 84.02M 50.85M 256.78M 80.83M 28.58M
Total Debt 4.24M 6.28M n/a 1.43M 14.93M
Common Stock 7.00K 7.00K 1K 1K 1K
Retained Earnings -304.95M -354.22M -155.84M -67.91M -25.63M
Comprehensive Income 197.00K -86.00K 9.00K -72.06M -7.67M
Shareholders Equity 433.43M 340.61M -151.17M -66.72M -25.36M
Total Investments 201.16M 284.42M 45.93M 189.00K n/a